Abstract

AIM of Study: To asses biochemical events in children with congenital heart disease in a tertiary hospital in Central India Background: Congenital Heart Disease (CHD) stands as a significant global health concern, representing a spectrum of structural anomalies in the heart and major blood vessels that originate during fetal development. It is estimated that approximately 1% of live births are affected by CHD, making it the most prevalent congenital disorder worldwide. The complexity of CHD ranges from relatively simple defects with minor clinical consequences to severe, life-threatening conditions that necessitate immediate medical intervention. By delving into the molecular intricacies, we aim to enhance our understanding of the etiological factors, identify potential therapeutic targets, and contribute to the development of personalized treatment strategies for children affected by CHD. Through this assessment, we aspire to bridge the gap between basic science and clinical practice, fostering advancements that will ultimately improve the lives of individuals born with congenital heart defects.

Description